Naoxintong Capsule for Secondary Prevention of Ischemic Stroke: A Multicenter, Randomized, and Placebo-Controlled Trial-Reference-Cited by-同舟云学术

Naoxintong Capsule for Secondary Prevention of Ischemic Stroke: A Multicenter, Randomized, and Placebo-Controlled Trial

Published:2022-10-17 Issue:12 Volume:28 Page:1063-1071
ISSN:1672-0415
Container-title:Chinese Journal of Integrative Medicine
language:en
Short-container-title:Chin. J. Integr. Med.

Author:

Yu Xiao-fei,Zhu Xu-ying,Yuan Can-xing,Wu Dan-hong,Zhao Yu-wu,Yang Jia-jun,Wang Chang-de,Wu Wei-wen,Liu Xue-yuan,Liu Zhen-guo,Nie Zhi-yu,Deng Ben-qiang,Bao Huan,Li Long-xuan,Wang Chun-yan,Zhang Hong-zhi,Zhang Jing-si,Huang Ji-han,Gong Fan,Wang Ming-zhe,Guo Yong-mei,Sun Yan,Cai Ding-fang

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Complementary and alternative medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11655-022-3586-8.pdf

Reference34 articles.

1. Zhou M, Wang H, Zhu J, Chen W, Wang L, Liu S, et al. Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the global burden of disease study 2013. Lancet 2016;387:251–272.

2. Wang LD, Yin L, Hua Y, Zuo Y, Wang YJ, Ji XM, et al. Fixed-dose combination treatment after stroke for secondary prevention in China: a national community-based study. Stroke 2015;46:1295–1300.

3. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet 2020;396:1204–1222.

4. Wang Y, Xu J, Zhao X, Wang D, Wang C, Liu L, et al. Association of hypertension with stroke recurrence depends on ischemic stroke subtype. Stroke 2013;44:1232–1237.

5. Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004;62:569–573.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Naoxintong capsule accelerates mitophagy in cerebral ischemia-reperfusion injury via TP53/PINK1/PRKN pathway based on network pharmacology analysis and experimental validation;Journal of Ethnopharmacology;2025-01

2. Analysis of online prescription patterns in Chinese patients with sequelae of cerebral infarction: a real-world study;Scientific Reports;2024-05-25

3. Efficacy of cerebroxin capsules combined with aspirin in prevention of post-ischemic stroke in patients treated with thrombolysis;Tropical Journal of Pharmaceutical Research;2024-03-12

4. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Explore the Thrombolytic Effects of Naoxintong Capsule on Rats of Focal Embolic Stroke;2024

5. Signaling pathways in brain ischemia: Mechanisms and therapeutic implications;Pharmacology & Therapeutics;2023-11